about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionEstimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 StudyBurden of Diarrhea in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population studyGlobal, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study.Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Health Effects of Overweight and Obesity in 195 Countries over 25 YearsGlobal, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort studyGender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran.The Global Burden of Cancer 2013Clinical features and long term outcome of 102 treated autoimmune hepatitis patients.Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran.Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study.Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran.The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.The Burden of Cardiovascular Diseases Among US States, 1990-2016.Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium
P50
Q21034169-2942CDAA-305B-4B85-BC2C-953B3675B664Q24170269-4B965654-35F3-481F-919C-DF400694325AQ28391248-7E8FEA53-D45E-4350-8EB9-011EDAD83F35Q28392340-E9BA703C-B411-4211-B2AE-1B727E0D0B4CQ28396370-31FAAE07-3C7F-401A-A2D7-43573D504986Q28476680-F5C25CF3-6B8C-4300-A657-57B4399C8961Q29616834-1C38C8D4-419E-4B05-9E50-EEA426410EB7Q30252707-DE1A0D94-B0A6-4109-9697-C0288D49B093Q30274748-9F98522C-65CE-4F6C-AA2C-4E5B3567973BQ30276050-24FD9187-3EAB-4DCE-A5C1-4CF11FEF1B83Q30358426-CF9298EB-FAE5-4712-AE43-9D0E29FC301DQ30402965-C17075E1-D7BF-420C-9E24-8FA78B590BEDQ30409179-B7AF647F-73B7-4146-B9D6-E840CC003499Q33632319-A2B6BF66-FB58-453C-90E1-B3E1F392C412Q33954722-7AC9FAAC-6807-4766-A866-94B778755995Q35642140-64D56C33-CD63-41EE-B915-EDEF53A64398Q35847426-301E3127-08EF-4F51-956F-1DBAF5DC8AF2Q35875283-0ABED9E9-366A-47AA-932A-854C85BF31AFQ36252176-99324818-7A05-47B0-B6A0-4EBE0DEB4CCBQ36376945-9F4D3003-8AA5-4522-83A2-3E57802C45A9Q38787080-8271557E-A85F-4099-A06F-54E6228EAF5EQ39008217-F89BCD79-8E85-45F9-A349-4B65948BEEAAQ39651256-1D4CFB9A-E44D-4513-AFDA-0BA545B0D8F8Q40262024-4CAA363C-D20C-480E-A952-35774E7F1928Q41679377-4F2A904D-44B0-4F63-9E04-589FCEE4425AQ41923187-B0EBC9A4-586E-48A6-9895-833C14DC3564Q52594017-89288A14-BF9E-4B2B-AB49-2FCA0C995608Q63682796-55D9E28F-26A7-474E-9AEA-61FEA28BE48D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sadaf G Sepanlou
@nl
Sadaf G Sepanlou
@sl
Sadaf G. Sepanlou
@en
Sadaf G. Sepanlou
@es
type
label
Sadaf G Sepanlou
@nl
Sadaf G Sepanlou
@sl
Sadaf G. Sepanlou
@en
Sadaf G. Sepanlou
@es
altLabel
Sepanlou SG
@en
prefLabel
Sadaf G Sepanlou
@nl
Sadaf G Sepanlou
@sl
Sadaf G. Sepanlou
@en
Sadaf G. Sepanlou
@es
P1053
H-9343-2016
P106
P1153
36248136000
P21
P31
P3829
P496
0000-0002-3669-5129
P569
2000-01-01T00:00:00Z